Cyclin D1 expression in papillary superficial bladder cancer: Its association with other cell cycle-associated proteins, cell proliferation and clinical outcome

International Journal of Cancer

Volumn 97, Issue 5, 2002, Pages 671-678

  Sgambato, Alessandro ^a   Migaldi, Mario ^b   Faraglia, Beatrice ^a   De Aloysio, Graziella ^b   Ferrari, Paolo ^b   Ardito, Raffaele ^a   De Gaetani, Carmela ^b   Capelli, Giovanni ^a   Cittadini, Achille ^a   Trentini, Gian Paolo ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Bladder cancer; CDK inhibitors; Cell cycle; Cyclin D1; Ki67; P21Waf1; P27Kip1; Prognosis

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; SUPERFICIAL CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CELL CYCLE PROTEINS; CELL DIVISION; COHORT STUDIES; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PLOIDIES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, ERBB-2; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 0037050747     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10055     Document Type: Article

References (56)

1. Cyclins, cyclin-dependent kinases and Cdk inhibitors: Implications in cell cycle control and cancer
2. Cell cycle control gene defects and human cancer
3. Abnormalities in cell cycle control in cancer and their clinical implications
4. Predicting prognosis in patients with superficial bladder cancer
5. Inhibitors of mammalian G1 cyclin-dependent kinases
6. Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers
7. Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers
8. Significance of cyclin D1 overexpression in transitional cell carcinoma of the urinary bladder and its correlation with histopathologic features
9. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification
10. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers
11. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer
12. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder
13. C-erbB-2 in bladder cancer: Molecular biology, correlation with epidermal growth factor receptors and prognostic value
14. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry
15. Convention on nomenclature for DNA cytometry (special report)
16. Proportional hazards tests and diagnostics based on weighted residuals
17. Correlation between mitotic and Ki-67 labeling indices in paraffin-embedded carcinoma specimen
18. Prognostic factors in bladder carcinoma: Histologic parameters and expression of a cell cycle related nuclear antigen (Ki-67)
19. Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67
20. Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors
21. Predictive value of cell cycle markers p53, MDM2, p21 and Ki-67 in superficial bladder tumor recurrence
22. D-type cyclins
23. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas
24. G1 phase progression: Cycling on cue
25. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression
26. J G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder
27. Expression of G1 → S transition regulatory molecules in human urothelial cancer
28. Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in the transitional cell carcinoma of the bladder
29. Cyclin D1 and prognosis in human breast cancer
30. Cyclin D1 overexpression in primary hypopharyngeal carcinomas
31. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth
32. Kip1, inhibits growth, and enhances apoptosis
33. Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death
34. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin e
35. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis
36. kip1 protein in human esophageal cancer cell lines that overexpress cyclin D1
37. Kip1 in human breast cancers
38. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: Comparison with DNA ploidy
39. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value
40. Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer
41. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis
42. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer
43. Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma
44. Cyclin D1 expression in non-small-cell lung cancers: Its association with altered p53 expression, cell proliferation and clinical outcome
45. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers
46. Cyclin D1 protein expression and function in human breast cancer
47. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer
48. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein
49. Cooperative effects of p53 and pRb alterations in primary superficial bladder tumors
50. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53
51. Proliferation in human bladder carcinoma measured by Ki-67 antibody labeling: Its potential clinical importance
52. Prognostic value of p53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder
53. Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: A long-term follow-up study